World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   2212 records for 358 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
Not RecruitingYesCTRI/2017/07/009035
A clinical trial to study the effects of two drugs SAIT101 and Rituximab for treatment in patients with low tumor of follicular lymphoma (cancer of the immune system)
12-07-2017
RecruitingYesNCT03164044
Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
22/05/2017
RecruitingNoNCT03164070
Study of the Laboratory-based Evaluation of the Degrees of Activity of Osteoarthritis
22/05/2017
RecruitingYesNCT03114631
Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer
11/04/2017
AuthorisedYesEUCTR2016-004045-81-BG
A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)
06/03/2017
RecruitingNoNCT03072576
Accuracy and Feasibility of Xpert Ultra
02/03/2017
RecruitingYesNCT03062644
Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.
20/02/2017
RecruitingYesNCT03033511
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2016-003503-64-ATA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)29/03/2017
AuthorisedEUCTR2016-003503-64-NLA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)02/05/2017
AuthorisedEUCTR2016-003503-64-ESA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)18/05/2017
AuthorisedEUCTR2016-003503-64-IEA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)24/04/2017
AuthorisedEUCTR2016-003503-64-HUA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)12/05/2017
AuthorisedEUCTR2016-003503-64-EEA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)13/03/2017
AuthorisedEUCTR2016-003503-64-DEA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)26/04/2017
AuthorisedEUCTR2016-003503-64-DKA Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)24/04/2017
25/01/2017
RecruitingYesNCT03021499
Aurinia Renal Response in Active Lupus With Voclosporin 12/01/2017
AuthorisedYesEUCTR2016-003874-42-GB
An efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency 03/01/2017
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history